Mitchener Stephen
SEC CIK 1774519 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | SVP, Chief Business Off | 128.3K | — | $22.6K | 5 | 2021-12-02 | 2023-03-01 |
Most active insiders at KPTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Paulson Richard A. | Pres, CEO, Dir | — | $137.2K |
| 2 | Poulton Stuart | EVP, Chief Development Off | — | $56.4K |
| 3 | Rangwala Reshma | EVP, Chief Medical Off | — | $55.6K |
| 4 | Cheng Sohanya Roshan | EVP, Chief Commercial Off | — | $46.4K |
| 5 | Mano Michael | SVP, GC, Sec | — | $35.7K |
| 6 | Macomber Lori | EVP, CFO, Treas | — | $10.2K |
| 7 | Abate Kristin | CAO | — | $10.0K |
| 8 | Su Zhen | Dir | — | — |
| 9 | Oliger Christy J. | Dir | — | — |
| 10 | Schor Chen | Dir | — | — |
Mitchener Stephen made no open-market trades at KPTI in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-03-01 | KPTI | Karyopharm Therapeutics Inc. | Mitchener Stephen | SVP, Chief Business Off | S - Sale | $3.03 | -6,357 | 128.3K | -5% | -$19.3K | |
| 2023-03-02 | 2023-02-28 | KPTI | Karyopharm Therapeutics Inc. | Mitchener Stephen | SVP, Chief Business Off | A - Grant | $0.00 | +60.0K | 134.7K | +80% | $0 | |
| D | 2022-09-01 | 2022-08-31 | KPTI | Karyopharm Therapeutics Inc. | Mitchener Stephen | SVP, Chief Business Off | A - Grant | $0.00 | +20.0K | 70.5K | +40% | $0 |
| D | 2022-03-02 | 2022-02-28 | KPTI | Karyopharm Therapeutics Inc. | Mitchener Stephen | SVP, Chief Business Off | A - Grant | $0.00 | +47.2K | 50.5K | +1,434% | $0 |
| 2021-12-03 | 2021-12-02 | KPTI | Karyopharm Therapeutics Inc. | Mitchener Stephen | SVP, Chief Business Off | S - Sale | $6.69 | -499 | 3,296 | -13% | -$3,338 |
Purchase Sale Sale after option exercise All abbreviations